Cyclophilins have been indicated as potential drug targets for cancer treatment due to their overexpression in a variety of cancer types [18,19] and their involvement in several cancer cell activities, such as protein folding, proliferation and cell cycle regulation [20,21,22,23]. This evidence concerns the gene PPIB and cancer.